DFX Intelligence

Data Factory

Private equityFirmbuyoutlower middle market

Bison Capital Advisors, LLC

Private Equity

Saint Louis, MO

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:c97cda36-fcf9-4039-b955-24d24e2e7ba9

Data as of Sep 13, 2026 (this record's last observation) from federal regulator filings. Page built Sep 21, 2026, 5:58 AM UTC and rebuilt at most every 15 minutes.

Relationships: 38
Dated events: 40
On other graphs: 5
Observed: Sep 13, 2026 to Sep 13, 2026
19 observations

Across DFX

same identity by shared identifier, citation, or a bridge measured by hand

Venture Capitalidentity

Bison Capital Advisors, LLC

Venture manager · cited, shared crd

Independent Sponsorsidentity

Bison Capital Advisors, LLC

Capital provider to sponsors · cited, shared crd

RIA / Wealth Managementidentity

BISON CAPITAL ADVISORS, LLC

Registered adviser · cited, shared crd

Allocatorsidentity

Bison Capital Advisors, LLC

Manager with allocator commitments · cited, shared crd

Private Creditidentity

BISON CAPITAL ADVISORS, LLC

Private credit manager · cited, shared crd

Facts

fact = as filed or announced; derived = computed by DFX; estimate = a band, never a point

Funds: 37
PE funds: 37
Vintages: 2023 to 2024
PE GAV, 2024 filing: $60.1Mgross asset value on Form ADV; never dry powder
Investments: 0
Active investments: 0
Size band: LOWER MIDDLE MARKETderivedproxy: $0.06bn Private Equity Fund GAV on the Form ADV filed 2024-03-27
Latest ADV filing: Mar 27, 2024

Funds

Fund	Vintage	Lifecycle	ADV type	Form D sold	GAV
Acm-Kypha Series B	2024	Unknown	Private Equity Fund	n/a	$253,000
Acm-Ideate Medical Partnership Tranche 5	2024	Unknown	Private Equity Fund	n/a	$470,280
Acm-Kypha Convertible Note	2024	Unknown	Private Equity Fund	n/a	$1.7M
Acm-Intershunt Convertible Note and Series B	2024	Unknown	Private Equity Fund	n/a	$569,000
Acm-Oct Convertible Note Partnership	2024	Unknown	Private Equity Fund	n/a	$338,000
Acm-Juristat A5	2023	Unknown	Private Equity Fund	n/a	$2.4M
Acm-Wellopp Series B-1 Partnership	2023	Unknown	Private Equity Fund	n/a	$323,750
Acm-Common Place Holdings	2023	Unknown	Private Equity Fund	n/a	$2.0M
ACM- Aptimmune Convertible Note Partnership	2023	Unknown	Private Equity Fund	n/a	$815,000
Acm-Ideate Medical Partnership	2023	Early deployment	Private Equity Fund	n/a	$3.0M
Acm-Deck Commerce Series a	2023	Wound down	Private Equity Fund	n/a	$459,000
Acm-Wellopp Series B Partnership	2023	Unknown	Private Equity Fund	n/a	$1.0M
Acm-Aptimmune Series a	2023	Unknown	Private Equity Fund	n/a	$2.7M
Acm-Short Term Credit Fund Partnership	2023	Early deployment	Private Equity Fund	n/a	$3.4M
Acm-Ideate Medical Part Tranche 3	2023	Early deployment	Private Equity Fund	n/a	$1.3M
Acm-Kypha Series B-1	2023	Early deployment	Private Equity Fund	n/a	$2.1M
Acm-Kypha Series a Partnership	2023	Unknown	Private Equity Fund	n/a	$9.4M
Acm-Wellopp Convertible Note	2023	Unknown	Private Equity Fund	n/a	$348,000
Acm-Juristat Series A-4a	2023	Unknown	Private Equity Fund	n/a	$1.1M
Acm-Deck Commerce Convertible Note	2023	Wound down	Private Equity Fund	n/a	$2.9M
Acm-Intershunt Technologies Series a Preferred	2023	Unknown	Private Equity Fund	n/a	$115,000
ACM- Bonfyre Series A-1	2023	Unknown	Private Equity Fund	n/a	$5.6M
Acm-Juristat Convertible Note	2023	Unknown	Private Equity Fund	n/a	$667,300
Acm-Harbor Medtech Series C Preferred	2023	Unknown	Private Equity Fund	n/a	$573,750
Acm-Harbor Medtech Series B Preferred	2023	Unknown	Private Equity Fund	n/a	$4.5M

Relationships

Employs (1)

→ Peter Frederick ReineckePersonManager
Nov 1, 2022 to presentfactForm ADV

Manages (37)

→ Ideate Medical Partnership Tranche 4FundVenture Capital Fund
Dec 20, 2022 to presentfactForm ADV
→ Acm-Common Place HoldingsFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Intershunt Technologies Series a PreferredFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Juristat A5FundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Juristat Convertible NoteFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Wellopp Series B-1 PartnershipFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ ACM- Bonfyre Convertible NoteFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Wellopp Convertible NoteFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Short Term Credit Fund PartnershipFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Wellopp Series B PartnershipFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Deck Commerce Convertible NoteFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Harbor Medtech Series C PreferredFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Ideate Medical PartnershipFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Ideate Medical Part Tranche 2FundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Aptimmune Series aFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Kypha Series a PartnershipFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ ACM- Bonfyre Series A-1FundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Ideate Medical Part Tranche 3FundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Deck Commerce Seed PreferredFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Kypha Series B-1FundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Short Term Credit Fund II PartnershipFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ ACM- Aptimmune Convertible Note PartnershipFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Intershunt TechnologiesFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Deck Commerce A-2 PartnershipFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Deck Commerce Series aFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Harbor Medtech Series B PreferredFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ ACM- Aptimmune Series BFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Bonfyre Series aFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ ACM- Bonfyre Series A-2FundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
→ Acm-Juristat Series A-4aFundPrivate Equity Fund
Mar 28, 2023 to presentfactForm ADV
and 7 more

Dated events

40 bookkeeping events (roster, classification and holdings changes) folded below

Show 40 bookkeeping events

Occurred
Aug 27, 2026
Bison Capital Advisors, LLC: Private Equity Funds on Form ADV 32 (2024 extract) -> 30 (roster 2026-09-01)
Occurred
Mar 27, 2024
Fund 805-8335079361 no longer reported on Form ADV by Bison Capital Advisors, LLC
Occurred
Mar 27, 2024
Acm-Kypha Series B first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $253,000
Occurred
Mar 27, 2024
Acm-Oct Convertible Note Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $338,000
Occurred
Mar 27, 2024
Acm-Intershunt Convertible Note and Series B first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $569,000
Occurred
Mar 27, 2024
Acm-Kypha Convertible Note first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $1,721,207
Occurred
Mar 27, 2024
Acm-Ideate Medical Partnership Tranche 5 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $470,280
Occurred
Mar 27, 2024
Fund 805-5320055960 no longer reported on Form ADV by Bison Capital Advisors, LLC
Occurred
Mar 27, 2024
Fund 805-9980098052 no longer reported on Form ADV by Bison Capital Advisors, LLC
Occurred
Mar 27, 2024
Fund 805-4607691920 no longer reported on Form ADV by Bison Capital Advisors, LLC
Occurred
Mar 27, 2024
Fund 805-4037126229 no longer reported on Form ADV by Bison Capital Advisors, LLC
Occurred
Mar 28, 2023
Acm-Deck Commerce Convertible Note first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $2,887,500
Occurred
Mar 28, 2023
Acm-Harbor Medtech Series C Preferred first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $573,750
Occurred
Mar 28, 2023
Acm-Ideate Medical Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $2,539,852
Occurred
Mar 28, 2023
Acm-Ideate Medical Part Tranche 2 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $590,586
Occurred
Mar 28, 2023
Acm-Aptimmune Series a first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $2,655,000
Occurred
Mar 28, 2023
Acm-Kypha Series a Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $9,377,000
Occurred
Mar 28, 2023
ACM- Bonfyre Series A-1 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $5,567,500
Occurred
Mar 28, 2023
Acm-Ideate Medical Part Tranche 3 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $1,106,455
Occurred
Mar 28, 2023
Acm-Deck Commerce Seed Preferred first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $3,318,500
Occurred
Mar 28, 2023
Acm-Kypha Series B-1 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $1,750,000
Occurred
Mar 28, 2023
Acm-Short Term Credit Fund II Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $200,000
Occurred
Mar 28, 2023
ACM- Aptimmune Convertible Note Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $815,000
Occurred
Mar 28, 2023
Acm-Intershunt Technologies first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $300,000
Occurred
Mar 28, 2023
Acm-Deck Commerce A-2 Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $333,000
Occurred
Mar 28, 2023
Acm-Deck Commerce Series a first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $459,000
Occurred
Mar 28, 2023
Acm-Harbor Medtech Series B Preferred first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $4,509,996
Occurred
Mar 28, 2023
Bonfyre Series a first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $750,000
Occurred
Mar 28, 2023
ACM- Bonfyre Series A-2 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $2,207,875
Occurred
Mar 28, 2023
Acm-Juristat Series A-4a first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $1,125,000
Occurred
Mar 28, 2023
Acm-Juristat Series A-4 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $1,519,256
Occurred
Mar 28, 2023
Acm-Kypha Series Seed Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $6,600,000
Occurred
Mar 28, 2023
ACM- Aptimmune Series B first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $2,255,000
Occurred
Mar 28, 2023
Acm-Common Place Holdings first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $2,000,000
Occurred
Mar 28, 2023
Acm-Intershunt Technologies Series a Preferred first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $115,000
Occurred
Mar 28, 2023
Acm-Juristat A5 first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $2,350,125
Occurred
Mar 28, 2023
Acm-Juristat Convertible Note first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $667,300
Occurred
Mar 28, 2023
Acm-Wellopp Series B-1 Partnership first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $350,000
Occurred
Mar 28, 2023
ACM- Bonfyre Convertible Note first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $856,750
Occurred
Mar 28, 2023
Acm-Wellopp Convertible Note first reported on Form ADV by Bison Capital Advisors, LLC (Private Equity Fund), GAV $378,000

Who to call

the organisation, the role and the published line, with the filing or website that published it; revealed to signed-in accounts

The firm's published line

Revealable: 1 business phone (Form ADV), 1 office address (Form ADV) · as of 2026-09-13

Also named here, with no published line of their own (reach them through the firm): Peter Frederick Reinecke (Manager).

Who to call is the organisation, the person's role and the line they published themselves: a business phone, office address, website or profile link from Form ADV, Form 13F or their own website, with that source named on every value. The counts above are what a reveal returns; a personal email is rarely published, so most reveals are the firm's line. Never data bought from a provider, never anything personal. Reveals by plan

Provenance

Graph: Private Equity
Canonical id: dfx:pe:c97cda36-fcf9-4039-b955-24d24e2e7ba9
First observed: Sep 13, 2026
Last observed: Sep 13, 2026 7 days ago
Source families: Federal regulator filings
2 registered feeds stand behind this record; each fact above carries its own dates and, where the publisher serves one, its document.
Resolution: Identity across graphs by shared identifier (CRD, CIK, EIN, ADV fund id, individual CRD) or citation; a name match is shown as a candidate and never merged.

Bison Capital Advisors, LLC

Private Equity

Saint Louis, MO

This is the graph view. The full profile, with its team, deals and sources, is on Private Equity.Open the full profile →

Search this name across graphsid dfx:pe:c97cda36-fcf9-4039-b955-24d24e2e7ba9

Data as of Sep 13, 2026 (this record's last observation) from federal regulator filings. Page built Sep 21, 2026, 5:58 AM UTC and rebuilt at most every 15 minutes.